[1] Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis,Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)[J]. Neurol Med Chir (Tokyo),2012,52(5):245-266. [2] 烟雾病和烟雾综合征诊断与治疗中国专家共识编写组,国家卫生计生委脑卒中防治专家委员会缺血性卒中外科专业委员会.烟雾病和烟雾综合征诊断与治疗中国专家共识[J].中华神经外科杂志,2017,33(6):541-547. [3] Zaharchuk G, Do H M, Marks M P, et al. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease[J]. Stroke, 2011, 42(9):2485-2491. [4] Barber P A, Demchuk A M, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta stroke programme early CT score[J]. Lancet, 2000,355(9216):1670-1674. [5] de Havenon A, Haynor D R, Tirschwell D L,et al. Association of collateral blood vessels detected by arterial spin labeling magnetic resonanceimaging with neurologic outcome after ischemic stroke[J]. JAMA Neurol, 2017,74(4):453-458. [6] Bokkers R P, Bremmer J P, van Berckel B N, et al. Arterial spin labeling perfusion MRI at multiple delay times:a correlative study with H(2)(15)O positron emission tomography in patients with symptomatic carotid artery occlusion[J]. J Cereb Blood Flow Metab,2010,30(1):222-229. [7] Noguchi T, Kawashima M, Irie H, et al. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging[J]. Eur J Radiol,2011,80(3):e557-e562. [8] Goetti R, O'Gorman R, Khan N, et al. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease:comparison with dynamic susceptibility contrast MRI[J]. Neuroradiology, 2013,55(5):639-647. [9] Ye F Q, Berman K F, Ellmore T, et al. H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans[J]. Magn Reson Med, 2000, 44(3):450-456. [10] Yuan J, Qu J, Zhang D,et al. Cerebral perfusion territory changes after direct revascularization surgery in moyamoya disease:a territory arterial spin labeling study[J]. World Neurosurg, 2019,122:e1128-e113. [11] Ishikawa T,Yamaguehi K,Kawashima A,et al. Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with moyamoya disease[J].World Neurosurg,2018,119:e750-e756. [12] 邱永逸,陈劲草,章剑剑, 等. 成人烟雾病STA-MCA分流术联合EMS后脑出血和高灌注综合征的关系[J].中国临床神经外科杂志,2019,24(7):387-389. [13] Qiao P G, Han C, Zuo Z W, et al. Clinical assessment of cerebral hemodynamics in moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging:a comparative study[J]. J Neuroradiol, 2017,44(4):273-280. [14] Hayashi K, Horie N, Suyama K, et al. Incidence and clinical features of symptomatic cerebral hyperperfusion syndrome after vascular reconstruction[J]. World Neurosurg, 2012, 78(5):447-454. |